Nalbuphine Hci Injection, Solution
Product Images NDC 51662-1420

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hci (NDC 51662-1420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Labeling (Box Labeling)

Nalbuphine HCl Injection 10 mg/mL folding carton label for a 1 x 10 mL multiple-dose fliptops vial. The label indicates IV, IM, and SC use and includes the manufacturer Hospira, a Pfizer company. The label also shows a barcode and storage instructions, along with preservative and buffer information in the inactive ingredients section.*

FDA Label Image

Boxed Warning (Boxed Warning)

Drug safety warning text panel for Nalbuphine Hydrochloride Injection highlighting serious risks of life-threatening respiratory depression, especially when used with opioids or CNS depressants like benzodiazepines and alcohol. It advises monitoring and limiting dosages, reserving co-prescribing for patients without alternatives, and watching for signs of respiratory depression and sedation.*

FDA Label Image

How Supplied (How Supplied)

A data table listing various NDC units of sale and their concentrations for a drug product. It includes single-dose ampuls and multiple-dose fliptop vials with concentrations ranging from 10 mg/mL to 200 mg/10 mL, specifying package sizes such as trays of 10 ampuls and cases of 25 vials.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Labeling (Serialized Labeling)

Packaging label of NALBUPHINE HCI Injection, 10 mg/mL, solution for injection available as 1 x 10 mL multiple-dose fliptop vial. The label shows the NDC 0409-1464-01 and indicates use by intravenous (IV), intramuscular (IM), and subcutaneous (SC) routes. The product is Rx only, distributed by HF Acquisition Co LLC, with Hospira branding.*

FDA Label Image

Structure (Structure)

Chemical structure of Nalbuphine Hydrochloride (NALBUPHINE HCI), showing the molecular arrangement of atoms including hydroxyl groups, nitrogen-containing rings, and associated hydrochloride.*

FDA Label Image

Vial Labeling (Vial Labeling)

Label for NALBUPHINE HCI Injection 10 mg/mL multiple-dose vial. It states use for intramuscular (I.M.), intravenous (I.V.), or subcutaneous (S.C.) administration. The label includes manufacturer Hospira, Inc. from Lake Forest, IL, USA, directions to protect from light, storage conditions at 20 to 25°C, and lists ingredients and preservatives in the solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.